ET
ABBV icon

Entropy Technologies’s AbbVie ABBV Stock Holding History

Entropy Technologies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Buy
+64,317
New +$13.8M 0.64% 16
2025
Q4 		– Sell
-8,841
Closed -$2.05M – 851
2025
Q3 		$2.05M Buy
+8,841
New +$1.8M 0.15% 184
2024
Q4 		– Sell
-1,267
Closed -$250K – 693
2024
Q3 		$250K Buy
+1,267
New +$236K 0.03% 589

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Entropy Technologies's ABBV Position: Q2 2026 in Review

Entropy Technologies opened a new position in AbbVie (ABBV) in Q2 2026: 64,317 shares worth $16.2M. The stake represents 0.64% of the portfolio and ranks #16 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in ABBV as recently as Q3 2025.

Entropy Technologies first reported a position in ABBV in Q3 2024 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Entropy Technologies held 64,317 shares of AbbVie worth $16.2M as of Q2 2026.
  • AbbVie was a new Entropy Technologies position in Q2 2026.
  • AbbVie made up 0.64% of Entropy Technologies's portfolio in Q2 2026, its #16 holding.
  • Entropy Technologies first reported a position in AbbVie in Q3 2024 and has held it in 3 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.